During the past decade, MED-POLONIA Sp.z o.o. conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 15 clinical trials were completed, i.e. on average, 27.8% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 11 clinical trials were completed. i.e. 36.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MED-POLONIA Sp.z o.o." #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Clovis Oncology, Inc." with 3 trials sponsored and "MacroGenics" with 3 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MED-POLONIA Sp.z o.o." #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "BeiGene" with 1 trials as a collaborator, "BioNTech SE" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "MED-POLONIA Sp.z o.o." are "Carcinoma, Non-Small-Cell Lung" (6 trials), "Neoplasms" (6 trials), "Non-small Cell Lung Cancer" (4 trials), "Melanoma" (3 trials) and "Non Small Cell Lung Cancer" (3 trials). Many other conditions were trialed in "MED-POLONIA Sp.z o.o." in a lesser frequency.

Most popular intervention types in "MED-POLONIA Sp.z o.o." are "Drug" (51 trials), "Biological" (9 trials), "Device" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Carboplatin" (7 trials), "Pemetrexed" (5 trials), "Cisplatin" (4 trials) and "Docetaxel" (4 trials). Other intervention names were less common.

The vast majority of trials in "MED-POLONIA Sp.z o.o." are 58 trials for "All" genders.

Currently, there are NaN active trials in "MED-POLONIA Sp.z o.o.". undefined are not yet recruiting, 13 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in MED-POLONIA Sp.z o.o., undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in MED-POLONIA Sp.z o.o., 12 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".